Renaissance

Wealth, Magnificence, and the Politics of a Usable Past

Why are old patterns returning to UI? A breakdown of Y2K, retrofuturism, brutalism, and skeuomorphism in modern interface design.

This paper synthesizes a structured deliberation among four AI models on a pressing question in technology strategy: does the rise of AI-native development tools-Cursor, Devin, Claude Artifacts,…

Pompous know-it-alls were once a mainstay of mockery on the Italian stage. Arnoud Visser investigates this stock character of the pedant and his association with individual superiority, social distinction, and sexual transgression, finding a form of satir

Artificial intelligence's ability to enrich science will depend not only on model capability, but also on whether researchers, reviewers and funders reward originality over speed.

In 2024, China's NMPA approved 83 new drugs, the FDA approved 50. China's share of new commercial clinical trials jumped from 8% globally in 2013 to 30% in 2024, just behind the US at 35%. Last year, China-based Jiangsu Hengrui Pharmaceuticals overtook As

The subtle and frustrating nature of manifold collapse

Autonomous drones may have killed soldiers for the first time.